Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is partial breast irradiation a step forward or backward?

Thomas A Buchholz1, Henry M Kuerer, Eric A Strom

  • 1Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. tbuchhol@mdanderson.org

Seminars in Radiation Oncology
|April 6, 2005
PubMed
Summary

Partial-breast irradiation (PBI) offers potential for early-stage breast cancer but requires large trials to confirm safety and efficacy. Without proper testing, PBI risks suboptimal patient outcomes and setbacks in radiation therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is Mastectomy Necessary in Patients with Occult Breast Cancer and Advanced (N2/N3) Nodal Disease?

Annals of surgical oncology·2026
Same author

ASO Visual Abstract: Is Mastectomy Necessary in Patients with Occult Breast Cancer and Advanced (N2/N3) Nodal Disease?

Annals of surgical oncology·2026
Same author

Lumpectomy Margins and Local Recurrence in DCIS: Results From the NRG Oncology/NSABP B-35 Randomized Clinical Trial.

JAMA surgery·2026
Same author

Essential details regarding the new omission of breast cancer surgery paradigm and the analysis of the JCOG 1806 trial.

International journal of clinical oncology·2026
Same author

Clipped Node Pathology as a Guide for Limited Axillary Surgery in Occult Breast Cancer.

Annals of surgery·2026
Same author

Eliminating breast cancer surgery in exceptional responders: selective omission - not blind omission.

Breast cancer research and treatment·2026

Area of Science:

  • Oncology
  • Radiation Therapy

Background:

  • Partial-breast irradiation (PBI) is emerging as a treatment for early-stage breast cancer.
  • Conventional whole-breast irradiation treats a larger tissue volume compared to PBI.

Purpose of the Study:

  • To evaluate the safety and efficacy of partial-breast irradiation (PBI) in early-stage breast cancer treatment.
  • To address uncertainties regarding recurrence risk and toxicity associated with PBI.

Main Methods:

  • The study emphasizes the need for large-scale clinical trials to validate PBI outcomes.
  • It highlights the importance of rigorous testing to ensure patient safety and treatment effectiveness.

Main Results:

  • Current widespread use of PBI outside clinical studies raises concerns about underreported poor outcomes.

Related Experiment Videos

  • Potential for increased recurrence risk due to smaller irradiated volume and dose inhomogeneity exists.

    • Conclusions:

    • Large clinical trials are essential to elucidate the benefits and limitations of PBI.
    • Adoption of PBI without proper validation may lead to suboptimal patient therapy and hinder advancements in breast cancer radiation treatment.